echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > "Pharmaceutical Speed ​​Reading Club" Ingram Medical's 700 million project exposes doctors to expose the shady of tumor treatment

    "Pharmaceutical Speed ​​Reading Club" Ingram Medical's 700 million project exposes doctors to expose the shady of tumor treatment

    • Last Update: 2021-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    [April 19, 2021/Medical Information List] Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan ; Puli Pharmaceuticals 500mg levofloxacin tablets obtained drug registration approval; Incorporated 700 million put into construction an annual output of 500,000 Tons of carboxyl-butadiene nitrile latex, 100,000 tons of DOTP project; Wantai Biotech's new crown antigen detection kit was approved to be sold in the German market.


    [April 19, 2021/list of medical information] ; Prily Pharmaceuticals 500mg levofloxacin tablets obtained drug registration approval; Ingram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP projects; Wantai Biotechnology The new crown antigen detection kit has been approved for sale in the German market.


    Part 1 Policy Brief Part 1 Policy Brief

    Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan

    Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan

    On the 19th, according to Jiangxi’s announcement, the domestic bivalent cervical cancer vaccine was launched in Jiangxi.


    180 pharmaceutical companies participate in a new round of centralized procurement in Fujian

    180 pharmaceutical companies participate in a new round of centralized procurement in Fujian

    Recently, the Fujian Medical Insurance Bureau issued the "Notice on Publicizing the Information of Fujian Province's Drug Centralized Purchase Products in 2021", stating that the application for bulk purchase of drugs in Fujian Province has been completed, and the list of companies and products that meet the application rules will now be announced , The publicity period is until April 22.


    Part 2 Observation of Sankei

    Part 2 Sankei Observation Part 2 Sankei Observation

    Ingram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP project

    Ingram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP project

    On the 19th, Intech Medical issued an announcement stating that the company's wholly-owned subsidiary, Anhui Intech, has invested 7 million yuan in the construction of an annual output of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP through the establishment of a holding subsidiary Anhui Kaize.


    Biolight intends to spend 11.


    Biolight intends to spend 11.


    Part 3 Drug News

    Part 3 Drug News Part 3 Drug News Information

    New antacid drugs! Shengnuo Medicine's Class 1 new drug initiates Phase 3 clinical trial of reflux esophagitis

    New antacid drugs! Shengnuo Medicine's Class 1 new drug initiates Phase 3 clinical trial of reflux esophagitis

    The latest news on the Chinese drug clinical trial registration and information disclosure platform, Shengnuo Pharmaceutical's new class 1 chemical drug X842 capsule has started a phase 3 clinical trial for the treatment of reflux esophagitis.


    FDA approves innovative oral contraceptive therapy containing new estrogen

    FDA approves innovative oral contraceptive therapy containing new estrogen

    A few days ago, Mayne Pharma announced that the US FDA has approved the company's Nextstellis (drospirenone and estrol compound tablets) to be marketed for the prevention of pregnancy.


    Shanghai Pharmaceutical Enalapril Maleate Tablets Passed the Consistency Evaluation

    Shanghai Pharmaceutical Enalapril Maleate Tablets Passed the Consistency Evaluation

    On the 19th, Shanghai Pharmaceutical issued an announcement stating that Xinya Minhang, a holding subsidiary, had received the "Drug Supplementary Application Approval Notice" (notice number) issued by the State Food and Drug Administration regarding enalapril maleate tablets (5mg, 10mg) : 2021B00893, 2021B00894), the drug passed the quality and efficacy consistency evaluation of generic drugs.


    Puli Pharmaceutical 500mg Levofloxacin Tablets Obtained Drug Registration Approval

    Puli Pharmaceutical 500mg Levofloxacin Tablets Obtained Drug Registration Approval

    Puli Pharmaceuticals issued an announcement stating that Zhejiang Puli Pharmaceutical Co.


    Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injection

    Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injection

    Poinsettia issued an announcement stating that its wholly-owned subsidiary Guangzhou Poinsettia Pharmaceutical Co.


    Hisun Pharmaceutical Tofacitib Citrate Tablets Obtained Drug Registration Certificate

    Hisun Pharmaceutical Tofacitib Citrate Tablets Obtained Drug Registration Certificate

    Hisun Pharmaceutical issued an announcement stating that the company had recently received tofacitib citrate tablets to obtain a drug registration certificate.


    Wantai Biotech's new crown antigen detection kit is approved for sale in the German market

    Wantai Biotech's new crown antigen detection kit is approved for sale in the German market

    Wantai Biological released an announcement stating that the company's new coronavirus antigen detection kit (colloidal gold method), with the German name WANTAISARS-CoV-2AgSchnelltest (KolloidalesGold), was recently approved by the German BfArM.


    Pfizer and Moderna refuse to cooperate with Johnson & Johnson on coagulation of the new crown vaccine

    Pfizer and Moderna refuse to cooperate with Johnson & Johnson on coagulation of the new crown vaccine

    According to a recent report by the Wall Street Journal, Johnson & Johnson contacted Pfizer, Moderna and AstraZeneca to ask them to investigate the coagulation problem caused by the COVID-19 vaccine and "express opinions on safety issues.


    Doctors from the Third Hospital of Beijing Medical University Reveal the Shady of Tumor Treatment

    Doctors from the Third Hospital of Beijing Medical University Reveal the Shady of Tumor Treatment

    On the 18th, a Zhihu user "Dr.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.